THERACARE Cold Hot Medicated Patch — Class II drug recall D-0066-2025
Terminated recall by Unexo Life Sciences Private Limited, reported 2024-12-04, distributed nationwide. cGMP Deviations
| Recall number | D-0066-2025 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Unexo Life Sciences Private Limited, New Delhi, India |
| Recall initiated | 2024-10-24 |
| Classified | 2024-11-22 |
| Reported by FDA | 2024-12-04 |
| Terminated | 2025-09-16 |
| Distributed | Nationwide (US) |
| Quantity | 279,936 patches |
| Reason classes | cgmp |
| UPC / GTIN / UDI-DI | 00845717008181 |
| NDC | 71101-0954, 71101-0954-05 |
Product
THERACARE Cold Hot Medicated Patch, Menthol 5%, 5 patches per box, Manufactured for: Veridian Healthcare, LLC, Gurnee, IL 60031 NDC 71101-954-05, UPC 8 45717 00818 1
Reason for recall
cGMP Deviations
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0066-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.